BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:This presentation provides an overview of Osteonecrosis of the Jaw (ONJ) and Medication-Related Osteonecrosis of the Jaw (MRONJ)\, focus ing on understanding its types\, definitions\, causes\, and management st rategies. Participants will learn to identify and describe the three prim ary types of ONJ and the core elements that define MRONJ. Dr. Beals will cover the indications for antiresorptive medications\, exploring the mec hanisms of action for drugs like Denosumab and Bisphosphonates\, and deta iling both anabolic and anti-catabolic medication categories. Additionall y\, the presentation will cover the pathophysiology\, stages\, and predis posing factors of MRONJ\, providing a solid foundation for understanding its progression and impact. It will also address treatment goals\, the Am erican Association of Oral and Maxillofacial Surgeons (AAOMS) guidelines\ , and local wound care practices that promote healing. Participants will e xamine the '4 Ds' of antiresorptive therapy\, the delayed dosing protocol \, and specialized decision-making tools\, such as the extraction and MRO NJ decision trees for Complex Dental Management and Assessment (CDMA) cas es. Through these elements\, the presentation aims to equip learners with practical strategies and evidence-based approaches for managing MRONJ in clinical settings. Course Objectives:At the conclusion of this course\, p articipants will:Identify and describe Osteonecrosis of the Jaw (ONJ) and Medication-Related ONJ (MRONJ)Explain the mechanisms of action and therape utic uses of medication involved in managing Osteonecrosis of the Jaw\, O NJ\, including antieresorptive and anabolic agentsDiscuss antiresorptive therapy and its guidelinesRecognize predisposing factors and treatment goa ls in MRONJRegister now! DTEND:20250514T013000Z DTSTAMP:20260711T170508Z DTSTART:20250514T000000Z LOCATION: SEQUENCE:0 SUMMARY:ACDE - Antiresorptive Medications and MRONJ UID:RFCALITEM639193863083884973 X-ALT-DESC;FMTTYPE=text/html:

This presentation provides an overview of O steonecrosis of the Jaw (ONJ) and Medication-Related Osteonecrosis of the Jaw (MRONJ)\, focusing on understanding its types\, definitions\, causes \, and management strategies. Participants will learn to identify and des cribe the three primary types of ONJ and the core elements that define MR ONJ. Dr. Beals will cover the indications for antiresorptive medications\ , exploring the mechanisms of action for drugs like Denosumab and Bispho sphonates\, and detailing both anabolic and anti-catabolic medication cat egories.

Additionally\, the presentation will cover the pathoph ysiology\, stages\, and predisposing factors of MRONJ\, providing a solid foundation for understanding its progression and impact. It will also ad dress treatment goals\, the American Association of Oral and Maxillofacia l Surgeons (AAOMS) guidelines\, and local wound care practices that promo te healing.

Participants will examine the '4 Ds' of antiresorpt ive therapy\, the delayed dosing protocol\, and specialized decision-maki ng tools\, such as the extraction and MRONJ decision trees for Complex De ntal Management and Assessment (CDMA) cases. Through these elements\, the presentation aims to equip learners with practical strategies and eviden ce-based approaches for managing MRONJ in clinical settings.

< strong>Course Objectives:

At the conclusion of this course\ , participants will:

Register now!

END:VEVENT END:VCALENDAR